Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials

Debate exists about the efficacy of β-blockers in myocardial infarction and their required duration of usage in contemporary practice. We conducted a MEDLINE/EMBASE/CENTRAL search for randomized trials evaluating β-blockers in myocardial infarction enrolling at least 100 patients. The primary outcom...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The American journal of medicine Ročník 127; číslo 10; s. 939
Hlavní autori:	Bangalore, Sripal, Makani, Harikrishna, Radford, Martha, Thakur, Kamia, Toklu, Bora, Katz, Stuart D, DiNicolantonio, James J, Devereaux, P J, Alexander, Karen P, Wetterslev, Jorn, Messerli, Franz H
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.10.2014
Predmet:	Adrenergic beta-Antagonists - administration & dosage Adrenergic beta-Antagonists - adverse effects Adrenergic beta-Antagonists - therapeutic use Cause of Death Comorbidity Databases, Bibliographic Heart Failure - epidemiology Humans Myocardial Infarction - drug therapy Myocardial Infarction - mortality Myocardial Infarction - therapy Myocardial Reperfusion - statistics & numerical data Randomized Controlled Trials as Topic Shock, Cardiogenic - epidemiology Time Factors Treatment Outcome Myocardial infarction β-blockers Reperfusion Outcomes
ISSN:	1555-7162, 1555-7162
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!